Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Posted on 03/02/2026
58:40 |

Featuring perspectives from Dr Hope S Rugo and Dr Sara M Tolaney, including the following topics:

  • Introduction: Long-Term Outcomes with Antibody-Drug Conjugates (0:00)
  • HER2-Positive Breast Cancer (8:02)
  • HER2-Negative Breast Cancer (32:41)

CME information and select publications